Table 1.
Patient characteristics
| Characteristic | Number |
|---|---|
| Median age (range) | 67.5 (20 – 87) |
| Sex—no. (%) | |
| Female | 32 (48.5) |
| Male | 34 (51.5) |
| Pathologic diagnosis – no. (%) | |
| DLBCL, nGCB | 47 (71.2) |
| DLBCL, GCB | 11 (16.7) |
| DLBCL, NOS | 3 (4.5) |
| PCNSL | 2 (3.0) |
| PMBCL | 2 (3.0) |
| FL | 1 (1.5) |
| IPI staging at diagnosis—no. (%) | |
| 0–1 | 16 (24.2) |
| 2 | 13 (19.7) |
| 3 | 12 (18.2) |
| 4–5 | 23 (34.8) |
| Not available (PCNSL patients) | 2 (3.0) |
| Previous line of treatment—no. (%) | |
| 1 | 32 (48.5) |
| 2 | 20 (30.3) |
| 3 or more§ | 14 (21.2) |
| Double expressor—no. (%) | |
| Yes | 17 (25.8) |
| No | 29 (43.9) |
| Not available | 20 (30.3) |
| Double hit—no. (%) | |
| Yes | 4 (6.1)‡ |
| No | 31 (47.0) |
| Not available | 31 (47.0) |
| ECOG performance at the enrollment—no. (%) | |
| 0 | 7 (10.6) |
| 1 | 53 (80.3) |
| 2 or more† | 6 (9.1) |
| Baseline LDH—median (IQR) | 333.5 (255.5, 534.8) |
Source data are provided as a Source Data file.
§One patient had previously undergone five lines of treatment including one autologous stem cell transplantation. None of the patients had previously received more than four lines of treatment.
†One patient had an ECOG performance status score of 3. The other patients had an ECOG performance status score of 2.
‡One patient had MYC, BCL2, and BCL6 translocation.
DLBCL diffuse large B-cell lymphoma, ECOG European Cooperative Oncology Group, FL follicular lymphoma, IPI International Prognostic Index, IQR interquartile range, GCB germinal center B-cell type, LDH lactate dehydrogenase, nGCB non-germinal center B-cell type, NOS not otherwise specified, PCNSL primary central nervous system lymphoma, PMBCL primary mediastinal B-cell lymphoma.